Antimicrobial peptides present in mammalian skin and gut are multifunctional defence molecules

Current Pharmaceutical Design

Volumn 16, Issue 9, 2010, Pages 1024-1039

  Metz Boutigue, Marie Hélène ^a   Shooshtarizadeh, Peiman ^a   Prevost, Gilles ^a   Haikel, Youssef ^a   Chich, Jean François ^a,b  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b INRA Institut National de la Recherche Agronomique   (France)

Author keywords

Antimicrobial peptides; Atopic dermatitis; Crohn's disease; Gut; Inflammation; Innate immunity; Psoriasis; Skin

Indexed keywords

ALPHA DEFENSIN; BETA DEFENSIN; BETA DEFENSIN 1; BETA DEFENSIN 2; BETA DEFENSIN 3; BETA DEFENSIN 4; BETA DEFENSIN 5; CALCITONIN GENE RELATED PEPTIDE; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CHROMOGRANIN A; DEFENSIN; DERMCIDIN; GAMMA INTERFERON; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; LACTOFERRIN; LECTIN; LYSOZYME; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; NEUROPEPTIDE; PHOSPHOLIPASE A2; POLYPEPTIDE ANTIBIOTIC AGENT; PSORIASIN; RIBONUCLEASE A; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 7; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE;

ADAPTIVE IMMUNITY; ATOPIC DERMATITIS; CROHN DISEASE; GASTROINTESTINAL MUCOSA; HOMEOSTASIS; HOST; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; IMMUNOREGULATION; IMMUNOSTIMULATION; INFECTION; INFLAMMATION; INJURY; INNATE IMMUNITY; MAMMAL; MICROBIAL GROWTH; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS; REVIEW; SKIN; ULCERATIVE COLITIS;

ADAPTIVE IMMUNITY; ANIMALS; ANTI-INFECTIVE AGENTS; GASTROINTESTINAL TRACT; HUMANS; IMMUNITY, INNATE; INFLAMMATORY BOWEL DISEASES; MAMMALS; MODELS, BIOLOGICAL; MODELS, MOLECULAR; PEPTIDE BIOSYNTHESIS; PEPTIDES; SKIN; SKIN DISEASES;

EID: 77950272369     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161210790963823     Document Type: Review

References (225)

1. Bulet P, Stocklin R, Menin L. Antimicrobial peptides: from invertebrates to vertebrates. Immunol Rev 2004; 198: 169-184
2. Aerts AM, Francois IE, Cammue BP, Thevissen K. The mode of antifungal action of plant, insect and human defensins. Cell Mol Life Sci 2008; 65: 2069-2079
3. Manners JM. Hidden weapons of microbial destruction in plant genomes. Genome Biol 2007; 8: 225.
4. Hultmark D, Steiner H, Rasmuson T, Boman HG. Insect immunity. Purification and properties of three inducible bactericidal proteins from hemolymph of immunized pupae of Hyalophora cecropia. Eur J Biochem 1980; 106: 7-16.
5. Lehrer RI, Selsted ME, Szklarek D, Fleischmann J. Antibacterial activity of microbicidal cationic proteins 1 and 2, natural peptide antibiotics of rabbit lung macrophages. Infect Immun 1983; 42: 10-14
6. Zasloff M. Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proc Natl Acad Sci USA 1987; 84: 5449-5453
7. Zanetti M. Cathelicidins, multifunctional peptides of the innate immunity. J Leukoc Biol 2004; 75: 39-48.
8. Yang D, Biragyn A, Kwak LW, Oppenheim JJ. Mammalian defensins in immunity: more than just microbicidal. Trends Immunol 2002; 23: 291-296
9. Cheung QC, Turner PV, Song C, Wu D, Cai HY, MacInnes JI, et al. Enhanced resistance to bacterial infection in protegrin-1 transgenic mice. Antimicrob Agents Chemother 2008; 52: 1812-1819
10. Kutta H, Willer A, Steven P, Brauer L, Tsokos M, Paulsen F. Distribution of mucins and antimicrobial substances lysozyme and lactoferrin in the laryngeal subglottic region. J Anat 2008; 213: 473-481
11. Almeida RP, Vanet A, Witko-Sarsat V, Melchior M, McCabe D, Gabay JE. Azurocidin, a natural antibiotic from human neutrophils: expression, antimicrobial activity, and secretion. Protein Exp Purif 1996; 7: 355-366
12. Gabay JE, Almeida RP. Antibiotic peptides and serine protease homologs in human polymorphonuclear leukocytes: defensins and azurocidin. Curr Opin Immunol 1993; 5: 97-102.
13. Kruse T, Kristensen HH. Using antimicrobial host defense peptides as anti-infective and immunomodulatory agents. Exp Rev Anti Infect Ther 2008; 6: 887-895
14. Wang Z, Wang G. APD: the antimicrobial peptide database. Nucleic Acids Res 2004; 32: D590-2.
15. Vazquez L, Alpuche J, Maldonado G, Agundis C, Pereyra-Morales A, Zenteno E. Review: immunity mechanisms in crustaceans. Innate Immun 2009; 15: 179-188
16. Tavares LS, Santos Mde O, Viccini LF, Moreira JS, Miller RN, Franco OL. Biotechnological potential of antimicrobial peptides from flowers. Peptides 2008; 29: 1842-1851
17. Oyston PC, Fox MA, Richards SJ, Clark GC. Novel peptide therapeutics for treatment of infections. J Med Microbiol 2009; 58: 977-987
18. Brogden KA, Guthmiller JM, Salzet M, Zasloff M. The nervous system and innate immunity: the neuropeptide connection. Nat Immunol 2005; 6: 558-564
19. Fales-Williams AJ, Brogden KA, Huffman E, Gallup JM, Ackermann MR. Cellular distribution of anionic antimicrobial peptide in normal lung and during acute pulmonary inflammation. Vet Pathol 2002; 39: 706-711
20. Yount NY, Bayer AS, Xiong YQ, Yeaman MR. Advances in antimicrobial peptide immunobiology. Biopolymers 2006; 84: 435-458
21. Durr UH, Sudheendra US, Ramamoorthy A. LL-37, the only human member of the cathelicidin family of antimicrobial peptides. Biochim Biophys Acta 2006; 1758: 1408-1425
22. Nijnik A, Hancock RE. The roles of cathelicidin LL-37 in immune defences and novel clinical applications. Curr Opin Hematol 2009; 16: 41-47
23. Khandelia H, Kaznessis YN. Cation-pi interactions stabilize the structure of the antimicrobial peptide indolicidin near membranes: molecular dynamics simulations. J Phys Chem B 2007; 111: 242-250
24. Niidome T, Mihara H, Oka M, Hayashi T, Saiki T, Yoshida K, et al. Structure and property of model peptides of proline/argininerich region in bactenecin 5. J Pept Res 1998; 51: 337-345
25. Brogden KA. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol 2005; 3: 238-250
26. Castagnola M, Inzitari R, Rossetti DV, Olmi C, Cabras T, Piras V, et al. A cascade of 24 histatins (histatin 3 fragments) in human saliva. Suggestions for a pre-secretory sequential cleavage pathway. J Biol Chem 2004; 279: 41436-41443
27. Oppenheim FG, Xu T, McMillian FM, Levitz SM, Diamond RD, Offner GD, et al. Histatins, a novel family of histidine-rich proteins in human parotid secretion. Isolation, characterization, primary structure, and fungistatic effects on Candida albicans. J Biol Chem 1988; 263: 7472-7477
28. Xu T, Levitz SM, Diamond RD, Oppenheim FG. Anticandidal activity of major human salivary histatins. Infect Immun 1991; 59: 2549-2554
29. Klotman ME, Chang TL. Defensins in innate antiviral immunity. Nat Rev Immunol 2006; 6: 447-456
30. Ostberg N, Kaznessis Y. Protegrin structure-activity relationships: using homology models of synthetic sequences to determine structural characteristics important for activity. Peptides 2005; 26: 197-206.
31. Bellamy W, Takase M, Wakabayashi H, Kawase K, Tomita M. Antibacterial spectrum of lactoferricin B, a potent bactericidal peptide derived from the N-terminal region of bovine lactoferrin. J Appl Bacteriol 1992; 73: 472-479
32. Viejo-Diaz M, Andres MT, Perez-Gil J, Sanchez M, Fierro JF. Potassium efflux induced by a new lactoferrin-derived peptide mimicking the effect of native human lactoferrin on the bacterial cytoplasmic membrane. Biochemistry (Mosc) 2003; 68: 217-227
33. Ringstad L, Andersson Nordahl E, Schmidtchen A, Malmsten M. Composition effect on peptide interaction with lipids and bacteria: variants of C3a peptide CNY21. Biophys J 2007; 92: 87-98.
34. Sonesson A, Ringstad L, Nordahl EA, Malmsten M, Morgelin M, Schmidtchen A. Antifungal activity of C3a and C3a-derived peptides against Candida. Biochim Biophys Acta 2007; 1768: 346-353
35. Tang YQ, Yeaman MR, Selsted ME. Antimicrobial peptides from human platelets. Infect Immun 2002; 70: 6524-6533
36. Yount NY, Gank KD, Xiong YQ, Bayer AS, Pender T, Welch WH, et al. Platelet microbicidal protein 1: structural themes of a multifunctional antimicrobial peptide. Antimicrob Agents Chemother 2004; 48: 4395-4404
37. Metz-Boutigue MH, Goumon Y, Strub JM, Lugardon K, Aunis D. Antimicrobial chromogranins and proenkephalin-A-derived peptides: Antibacterial and antifungal activities of chromogranins and proenkephalin-A-derived peptides. Ann NY Acad Sci 2003; 992: 168-178
38. Radek K, Gallo R. Antimicrobial peptides: natural effectors of the innate immune system. Semin Immunopathol 2007; 29: 27-43.
39. Yang D, Chen Q, Hoover DM, Staley P, Tucker KD, Lubkowski J, et al. Many chemokines including CCL20/MIP-3α display antimicrobial activity. J Leukoc Biol 2003; 74: 448-455
40. Keshav S. Paneth cells: leukocyte-like mediators of innate immunity in the intestine. J Leukoc Biol 2006; 80: 500-508
41. Schroder JM, Harder J. Antimicrobial skin peptides and proteins. Cell Mol Life Sci 2006; 63: 469-486
42. Mookherjee N, Hancock RE. Cationic host defence peptides: innate immune regulatory peptides as a novel approach for treating infections. Cell Mol Life Sci 2007; 64: 922-933
43. Briolat J, Wu SD, Mahata SK, Gonthier B, Bagnard D, Chasserot-Golaz S, et al. New antimicrobial activity for the catecholamine release-inhibitory peptide from chromogranin A. Cell Mol Life Sci 2005; 62: 377-385
44. Goumon Y, Lugardon K, Kieffer B, Lefevre JF, Van Dorsselaer A, Aunis D, et al. Characterization of antibacterial COOH-terminal proenkephalin-A-derived peptides (PEAP) in infectious fluids. Importance of enkelytin, the antibacterial PEAP209-237 secreted by stimulated chromaffin cells. J Biol Chem 1998; 273: 29847-29856
45. Lugardon K, Raffner R, Goumon Y, Corti A, Delmas A, Bulet P, et al. Antibacterial and antifungal activities of vasostatin-1, the N-terminal fragment of chromogranin A. J Biol Chem 2000; 275: 10745-10753
46. Strub JM, Garcia-Sablone P, Lonning K, Taupenot L, Hubert P, Van Dorsselaer A, et al. Processing of chromogranin B in bovine adrenal medulla. Identification of secretolytin, the endogenous C-terminal fragment of residues 614-626 with antibacterial activity. Eur J Biochem 1995; 229: 356-368
47. Hertz CJ, Wu Q, Porter EM, Zhang YJ, Weismuller KH, Godowski PJ, et al. Activation of Toll-like receptor 2 on human tracheobronchial epithelial cells induces the antimicrobial peptide human beta defensin-2. J Immunol 2003; 171: 6820-6826
48. Liu L, Roberts AA, Ganz T. By IL-1 signaling, monocyte-derived cells dramatically enhance the epidermal antimicrobial response to lipopolysaccharide. J Immunol 2003; 170: 575-580
49. Vora P, Youdim A, Thomas LS, Fukata M, Tesfay SY, Lukasek K, et al. β-defensin-2 expression is regulated by TLR signaling in intestinal epithelial cells. J Immunol 2004; 173: 5398-5405
50. Wang G, Feng Y, Wang Y, Huang N, Wu Q, Wang B. Bifidobacterium cell wall proteins induced β-defensin 2 mRNA expression in human intestinal epithelial cells. Sichuan Da Xue Xue Bao Yi Xue Ban 2003; 34: 622-624
51. Wolk K, Kunz S, Witte E, Friedrich M, Asadullah K, Sabat R. IL-22 increases the innate immunity of tissues. Immunity 2004; 21: 241-254
52. Peyrin-Biroulet L, Vignal C, Dessein R, Simonet M, Desreumaux P, Chamaillard M. NODs in defence: from vulnerable antimicrobial peptides to chronic inflammation. Trends Microbiol 2006; 14: 432-438
53. Boughan PK, Argent RH, Body-Malapel M, Park JH, Ewings KE, Bowie AG, et al. Nucleotide-binding oligomerization domain-1 and epidermal growth factor receptor: critical regulators of beta-defensins during Helicobacter pylori infection. J Biol Chem 2006; 281: 11637-11648
54. Imler JL, Hoffmann JA. Toll receptors in innate immunity. Trends Cell Biol 2001; 11: 304-311
55. Li M, Zhou Y, Feng G, Su SB. The critical role of Toll-like receptor signaling pathways in the induction and progression of autoimmune diseases. Curr Mol Med 2009; 9: 365-374
56. Iwasaki A, Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol 2004; 5: 987-995
57. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006; 124: 783-801.
58. Hussain T, Nasreen N, Lai Y, Bellew BF, Antony VB, Mohammed KA. Innate immune responses in murine pleural mesothelial cells: Toll-like receptor-2 dependent induction of β-defensin-2 by staphylococcal peptidoglycan. Am J Physiol Lung Cell Mol Physiol 2008; 295: L461-70.
59. Davies D, Meade KG, Herath S, Eckersall PD, Gonzalez D, White JO, et al. Sheldon IM. Toll-like receptor and antimicrobial peptide expression in the bovine endometrium. Reprod Biol Endocrinol 2008; 6: 53.
60. Varoga D, Klostermeier E, Paulsen F, Wruck C, Lippross S, Brandenburg LO, et al. The antimicrobial peptide HBD-2 and the Toll-like receptors-2 and -4 are induced in synovial membranes in case of septic arthritis. Virchows Arch 2009; 454: 685-694
61. Schlapbach C, Yawalkar N, Hunger RE. Human β-defensin-2 and psoriasin are overexpressed in lesions of acne inversa. J Am Acad Dermatol 2009; 61: 58-65.
62. Glaser R, Meyer-Hoffert U, Harder J, Cordes J, Wittersheim M, Kobliakova J, et al. The antimicrobial protein psoriasin (S100A7) is upregulated in atopic dermatitis and after experimental skin barrier disruption. J Invest Dermatol 2009; 129: 641-649
63. Yoneyama M, Fujita T. RIG-I: critical regulator for virus-induced innate immunity. Tanpakushitsu Kakusan Koso 2004; 49: 2571-2578
64. Kanneganti TD, Lamkanfi M, Nunez G. Intracellular NOD-like receptors in host defense and disease. Immunity 2007; 27: 549-559
65. Wehkamp J, Wang G, Kubler I, Nuding S, Gregorieff A, Schnabel A, et al. The Paneth cell alpha-defensin deficiency of ileal Crohn's disease is linked to Wnt/Tcf-4. J Immunol 2007; 179: 3109-3118
66. Schauber J, Gallo RL. Antimicrobial peptides and the skin immune defense system. J Allergy Clin Immunol 2008; 122: 261-266
67. Hao HN, Zhao J, Lotoczky G, Grever WE, Lyman WD. Induction of human beta-defensin-2 expression in human astrocytes by lipopolysaccharide and cytokines. J Neurochem 2001; 77: 1027-1035
68. Bergman P, Gudmundsson GH, Agerberth B. Natural immunity first line defense. New treatment against infections and autoimmune diseases in sight. Lakartidningen 2008; 105: 2254-2259
69. Radermacher SW, Schoop VM, Schluesener HJ. Bactenecin, a leukocytic antimicrobial peptide, is cytotoxic to neuronal and glial cells. J Neurosci Res 1993; 36: 657-662
70. Schikorski D, Cuvillier-Hot V, Leippe M, Boidin-Wichlacz C, Slomianny C, Macagno E, et al. Microbial challenge promotes the regenerative process of the injured central nervous system of the medicinal leech by inducing the synthesis of antimicrobial peptides in neurons and microglia. J Immunol 2008; 181: 1083-1095
71. Braff MH, Bardan A, Nizet V, Gallo RL. Cutaneous defense mechanisms by antimicrobial peptides. J Invest Dermatol 2005; 125: 9-13.
72. Kai-Larsen Y, Agerberth B. The role of the multifunctional peptide LL-37 in host defense. Front Biosci 2008; 13: 3760-3767
73. Yang D, Chertov O, Bykovskaia SN, Chen Q, Buffo MJ, Shogan J, et al. β-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 1999; 286: 525-528
74. Befus AD, Mowat C, Gilchrist M, Hu J, Solomon S, Bateman A. Neutrophil defensins induce histamine secretion from mast cells: mechanisms of action. J Immunol 1999; 163: 947-953
75. Eliasson M, Egesten A. Antibacterial chemokines - actors in both innate and adaptive immunity. Contrib Microbiol 2008; 15: 101-117
76. Simpson AJ, Maxwell AI, Govan JR, Haslett C, Sallenave JM. Elafin (elastase-specific inhibitor) has antimicrobial activity against gram-positive and gram-negative respiratory pathogens. FEBS Lett 1999; 452: 309-313
77. McMichael JW, Maxwell AI, Hayashi K, Taylor K, Wallace WA, Govan JR, et al. Antimicrobial activity of murine lung cells against Staphylococcus aureus is increased in vitro and in vivo after elafin gene transfer. Infect Immun 2005; 73: 3609-3617
78. McMichael JW, Roghanian A, Jiang L, Ramage R, Sallenave JM. The antimicrobial antiproteinase elafin binds to lipopolysaccharide and modulates macrophage responses. Am J Respir Cell Mol Biol 2005; 32: 443-452
79. Kato A, Schleimer RP. Beyond inflammation: airway epithelial cells are at the interface of innate and adaptive immunity. Curr Opin Immunol 2007; 19: 711-720
80. Peyrin-Biroulet L, Chamaillard M. NOD2 and defensins: translating innate to adaptive immunity in Crohn's disease. J Endotoxin Res 2007; 13: 135-139
81. Elias PM. The skin barrier as an innate immune element. Semin Immunopathol 2007; 29: 3-14.
82. Ogawa H, Miyazaki H, Kimura M. Isolation and characterization of human skin lysozyme. J Invest Dermatol 1971; 57: 111-116
83. Papini M, Simonetti S, Franceschini S, Scaringi L, Binazzi M. Lysozyme distribution in healthy human skin. Arch Dermatol Res 1982; 272: 167-170
84. Walker VP, Akinbi HT, Meinzen-Derr J, Narendran V, Visscher M, Hoath SB. Host defense proteins on the surface of neonatal skin: implications for innate immunity. J Pediatr 2008; 152: 777-781
85. Bellamy W, Wakabayashi H, Takase M, Kawase K, Shimamura S, Tomita M. Killing of Candida albicans by lactoferricin B, a potent antimicrobial peptide derived from the N-terminal region of bovine lactoferrin. Med Microbiol Immunol 1993; 182: 97-105.
86. Legrand D, Elass E, Carpentier M, Mazurier J. Lactoferrin: a modulator of immune and inflammatory responses. Cell Mol Life Sci 2005; 62: 2549-2559
87. Kansal RG, Aziz RK, Kotb M. Modulation of expression of superantigens by human transferrin and lactoferrin: a novel mechanism in host-Streptococcus interactions. J Infect Dis 2005; 191: 2121-2129
88. Schittek B, Hipfel R, Sauer B, Bauer J, Kalbacher H, Stevanovic S, et al. Dermcidin: a novel human antibiotic peptide secreted by sweat glands. Nat Immunol 2001; 2: 1133-1137
89. Baechle D, Flad T, Cansier A, Steffen H, Schittek B, Tolson J, et al. Cathepsin D is present in human eccrine sweat and involved in the postsecretory processing of the antimicrobial peptide DCD-1L. J Biol Chem 2006; 281: 5406-5415
90. Lai Y, Villaruz AE, Li M, Cha DJ, Sturdevant DE, Otto M. The human anionic antimicrobial peptide dermcidin induces proteolytic defence mechanisms in staphylococci. Mol Microbiol 2007; 63: 497-506.
91. Rieg S, Seeber S, Steffen H, Humeny A, Kalbacher H, Stevanovic S, et al. Generation of multiple stable dermcidin-derived antimicrobial peptides in sweat of different body sites. J Invest Dermatol 2006; 126: 354-365
92. Steffen H, Rieg S, Wiedemann I, Kalbacher H, Deeg M, Sahl HG, et al. Naturally processed dermcidin-derived peptides do not permeabilize bacterial membranes and kill microorganisms irrespective of their charge. Antimicrob Agents Chemother 2006; 50: 2608-2620
93. Shaw JL, Smith CR, Diamandis EP. Proteomic analysis of human cervico-vaginal fluid. J Proteome Res 2007; 6: 2859-2865
94. Lee Motoyama JP, Kim-Motoyama H, Kim P, Nakagama H, Miyagawa K, Suzuki K. Identification of dermcidin in human gestational tissue and characterization of its proteolytic activity. Biochem Biophys Res Commun 2007; 357: 828-833
95. Dyer KD, Rosenberg HF. The RNase a superfamily: generation of diversity and innate host defense. Mol Divers 2006; 10: 585-597
96. Lehrer RI, Szklarek D, Barton A, Ganz T, Hamann KJ, Gleich GJ. Antibacterial properties of eosinophil major basic protein and eosinophil cationic protein. J Immunol 1989; 142: 4428-4434
97. Harder J, Schroder JM. RNase 7, a novel innate immune defense antimicrobial protein of healthy human skin. J Biol Chem 2002; 277: 46779-46784
98. Abtin A, Eckhart L, Mildner M, Ghannadan M, Harder J, Schroder JM, et al. Degradation by stratum corneum proteases prevents endogenous RNase inhibitor from blocking antimicrobial activities of RNase 5 and RNase 7. J Invest Dermatol 2009; 129: 2193-2201
99. Boni R, Burg G, Doguoglu A, Ilg EC, Schafer BW, Muller B, et al. Immunohistochemical localization of the Ca2+ binding S100 proteins in normal human skin and melanocytic lesions. Br J Dermatol 1997; 137: 39-43.
100. Broome AM, Ryan D, Eckert RL. S100 protein subcellular localization during epidermal differentiation and psoriasis. J Histochem Cytochem 2003; 51: 675-685
101. Del Valle ME, Vazquez E, Represa J, Malinovsky L, Vega JA. Immunohistochemical localization of calcium-binding proteins in the human cutaneous sensory corpuscles. Neurosci Lett 1994; 168: 247-250
102. Jinquan T, Vorum H, Larsen CG, Madsen P, Rasmussen HH, Gesser B, et al. Psoriasin: a novel chemotactic protein. J Invest Dermatol 1996; 107: 5-10.
103. Martinsson H, Yhr M, Enerback C. Expression patterns of S100A7 (psoriasin) and S100A9 (calgranulin-B) in keratinocyte differentiation. Exp Dermatol 2005; 14: 161-168
104. Eckert RL, Broome AM, Ruse M, Robinson N, Ryan D, Lee K. S100 proteins in the epidermis. J Invest Dermatol 2004; 123: 23-33.
105. Zheng Y, Niyonsaba F, Ushio H, Ikeda S, Nagaoka I, Okumura K, et al. Microbicidal protein psoriasin is a multifunctional modulator of neutrophil activation. Immunology 2008; 124: 357-367
106. Oren A, Ganz T, Liu L, Meerloo T. In human epidermis, beta-defensin 2 is packaged in lamellar bodies. Exp Mol Pathol 2003; 74: 180-182
107. Butmarc J, Yufit T, Carson P, Falanga V. Human β-defensin-2 expression is increased in chronic wounds. Wound Repair Regen 2004; 12: 439-443
108. Harder J, Bartels J, Christophers E, Schroder JM. A peptide antibiotic from human skin. Nature 1997; 387: 861.
109. Bals R, Wang X, Zasloff M, Wilson JM. The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Proc Natl Acad Sci USA 1998; 95: 9541-9546
110. Ganz T. Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol 2003; 3: 710-720
111. Kanda N, Watanabe S. IL-12, IL-23, and IL-27 enhance human beta-defensin-2 production in human keratinocytes. Eur J Immunol 2008; 38: 1287-1296
112. Sorensen OE, Thapa DR, Rosenthal A, Liu L, Roberts AA, Ganz T. Differential regulation of β-defensin expression in human skin by microbial stimuli. J Immunol 2005; 174: 4870-4879
113. Ali RS, Falconer A, Ikram M, Bissett CE, Cerio R, Quinn AG. Expression of the peptide antibiotics human beta defensin-1 and human beta defensin-2 in normal human skin. J Invest Dermatol 2001; 117: 106-111
114. Harder J, Meyer-Hoffert U, Wehkamp K, Schwichtenberg L, Schroder JM. Differential gene induction of human β-defensins (hBD-1, -2, -3, and -4) in keratinocytes is inhibited by retinoic acid. J Invest Dermatol 2004; 123: 522-529
115. Lichti U, Anders J, Yuspa SH. Isolation and short-term culture of primary keratinocytes, hair follicle populations and dermal cells from newborn mice and keratinocytes from adult mice for in vitro analysis and for grafting to immunodeficient mice. Nat Prot 2008; 3: 799-810.
116. Sorensen OE, Thapa DR, Roupe KM, Valore EV, Sjobring U, Roberts AA, et al. Injury-induced innate immune response in human skin mediated by transactivation of the epidermal growth factor receptor. J Clin Invest 2006; 116: 1878-1885
117. Garcia JR, Jaumann F, Schulz S, Krause A, Rodriguez-Jimenez J, Forssmann U, et al. Identification of a novel, multifunctional β-defensin (human β-defensin 3) with specific antimicrobial activity. Its interaction with plasma membranes of Xenopus oocytes and the induction of macrophage chemoattraction. Cell Tissue Res 2001; 306: 257-264
118. Harder J, Bartels J, Christophers E, Schroder JM. Isolation and characterization of human β -defensin-3, a novel human inducible peptide antibiotic. J Biol Chem 2001; 276: 5707-5713
119. Niyonsaba F, Ushio H, Nakano N, Ng W, Sayama K, Hashimoto K, et al. Antimicrobial peptides human β-defensins stimulate epidermal keratinocyte migration, proliferation and production of proinflammatory cytokines and chemokines. J Invest Dermatol 2007; 127: 594-604.
120. Sternberg EM. Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens. Nat Rev Immunol 2006; 6: 318-328
121. Webster JI, Tonelli L, Sternberg EM. Neuroendocrine regulation of immunity. Annu Rev Immunol 2002; 20: 125-163
122. Lucarz A, Brand G. Current considerations about Merkel cells. Eur J Cell Biol 2007; 86: 243-251
123. Hartschuh W, Weihe E, Yanaihara N. Immunohistochemical analysis of chromogranin A and multiple peptides in the mammalian Merkel cell: further evidence for its paraneuronal function? Arch Histol Cytol 1989; 52 (Suppl): 423-431
124. Hartschuh W, Weihe E, Egner U. Chromogranin A in the mammalian Merkel cell: cellular and subcellular distribution. J Invest Dermatol 1989; 93: 641-648
125. Wikberg JE, Muceniece R, Mandrika I, Prusis P, Lindblom J, Post C, et al. New aspects on the melanocortins and their receptors. Pharmacol Res 2000; 42: 393-420.
126. Pritchard LE, White A. Neuropeptide processing and its impact on melanocortin pathways. Endocrinology 2007; 148: 4201-4207
127. Cutuli M, Cristiani S, Lipton JM, Catania A. Antimicrobial effects of α-MSH peptides. J Leukoc Biol 2000; 67: 233-239
128. Hiltz ME, Lipton JM. Alpha-MSH peptides inhibit acute inflammation and contact sensitivity. Peptides 1990; 11: 979-982
129. Mandrika I, Muceniece R, Wikberg JE. Effects of melanocortin peptides on lipopolysaccharide/interferon-γ-induced NF-κB DNA binding and nitric oxide production in macrophage-like RAW 264.7 cells: evidence for dual mechanisms of action. Biochem Pharmacol 2001; 61: 613-621
130. Mugridge KG, Perretti M, Ghiara P, Parente L. α-melanocyte- stimulating hormone reduces interleukin-1 β effects on rat stomach preparations possibly through interference with a type I receptor. Eur J Pharmacol 1991; 197: 151-155
131. Sawyer TK, Staples DJ, Castrucci AM, Hadley ME, al-Obeidi FA, Cody WL, et al. α-melanocyte stimulating hormone message and inhibitory sequences: comparative structure-activity studies on melanocytes. Peptides 1990; 11: 351-357
132. Helle KB, Corti A, Metz-Boutigue MH, Tota B. The endocrine role for chromogranin A: a prohormone for peptides with regulatory properties. Cell Mol Life Sci 2007; 64: 2863-2886
133. Lugardon K, Chasserot-Golaz S, Kieffer AE, Maget-Dana R, Nullans G, Kieffer B, et al. Structural and biological characterization of chromofungin, the antifungal chromogranin A-(47-66)-derived peptide. J Biol Chem 2001; 276: 35875-35882
134. Kruger PG, Mahata SK, Helle KB. Catestatin (CgA344-364) stimulates rat mast cell release of histamine in a manner comparable to mastoparan and other cationic charged neuropeptides. Regul Pept 2003; 114: 29-35.
135. Zeeuwen PL, de Jongh GJ, Rodijk-Olthuis D, Kamsteeg M, Verhoosel RM, van Rossum MM, et al. Genetically programmed differences in epidermal host defense between psoriasis and atopic dermatitis patients. PLoS One 2008; 3: e2301.
136. Yamasaki K, Gallo RL. Antimicrobial peptides in human skin disease. Eur J Dermatol 2008; 18: 11-21.
137. Henseler T, Christophers E. Disease concomitance in psoriasis. J Am Acad Dermatol 1995; 32: 982-986
138. Bonness S, Bieber T. Molecular basis of atopic dermatitis. Curr Opin Allergy Clin Immunol 2007; 7: 382-386
139. Sarker SA, Gyr K. Non-immunological defence mechanisms of the gut. Gut 1992; 33: 987-993
140. Muller CA, Autenrieth IB, Peschel A. Innate defenses of the intestinal epithelial barrier. Cell Mol Life Sci 2005; 62: 1297-1307
141. Mason DY, Taylor CR. The distribution of muramidase (lysozyme) in human tissues. J Clin Pathol 1975; 28: 124-132
142. Satoh Y, Ishikawa K, Tanaka H, Oomori Y, Ono K. Immunohistochemical observations of lysozyme in the Paneth cells of specific-pathogen-free and germ-free mice. Acta Histochem 1988; 83: 185-188
143. Artym J, Zimecki M, Kuryszko J, Kruzel ML. Lactoferrin accelerates reconstitution of the humoral and cellular immune response during chemotherapy-induced immunosuppression and bone marrow transplant in mice. Stem Cells Dev 2005; 14: 548-555
144. Muller FM, Morschhauser J, Kohler G, Oelschlaeger TA, Ziebuhr W, Hacker J. Adherence and invasion-two pathogenicity factors in bacterial and fungal pathogens. Mycoses 1999; 42 (Suppl 1): 39-42.
145. Valentin E, Ghomashchi F, Gelb MH, Lazdunski M, Lambeau G. On the diversity of secreted phospholipases A(2). Cloning, tissue distribution, and functional expression of two novel mouse group II enzymes. J Biol Chem 1999; 274: 31195-31202
146. Zayat M, Lichtenberger LM, Dial EJ. Pathophysiology of LPS-induced gastrointestinal injury in the rat: role of secretory phospholipase A2. Shock 2008; 30: 206-211
147. Romeo D, Skerlavaj B, Bolognesi M, Gennaro R. Structure and bactericidal activity of an antibiotic dodecapeptide purified from bovine neutrophils. J Biol Chem 1988; 263: 9573-9575
148. Hase K, Eckmann L, Leopard JD, Varki N, Kagnoff MF. Cell differentiation is a key determinant of cathelicidin LL-37/human cationic antimicrobial protein 18 expression by human colon epithelium. Infect Immun 2002; 70: 953-963
149. Koczulla R, von Degenfeld G, Kupatt C, Krotz F, Zahler S, Gloe T, et al. An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J Clin Invest 2003; 111: 1665-1672
150. Davidson DJ, Currie AJ, Reid GS, Bowdish DM, MacDonald KL, Ma RC, et al. The cationic antimicrobial peptide LL-37 modulates dendritic cell differentiation and dendritic cell-induced T cell polarization. J Immunol 2004; 172: 1146-1156
151. Yu J, Mookherjee N, Wee K, Bowdish DM, Pistolic J, Li Y, et al. Host defense peptide LL-37, in synergy with inflammatory mediator IL-1β, augments immune responses by multiple pathways. J Immunol 2007; 179: 7684-7691
152. Mookherjee N, Brown KL, Bowdish DM, Doria S, Falsafi R, Hokamp K, et al. Modulation of the TLR-mediated inflammatory response by the endogenous human host defense peptide LL-37. J Immunol 2006; 176: 2455-2464
153. Hooper LV, Stappenbeck TS, Hong CV, Gordon JI. Angiogenins: a new class of microbicidal proteins involved in innate immunity. Nat Immunol 2003; 4: 269-273
154. Saxena SK, Rybak SM, Davey RT, Jr., Youle RJ, Ackerman EJ. Angiogenin is a cytotoxic, tRNA-specific ribonuclease in the RNase A superfamily. J Biol Chem 1992; 267: 21982-21986
155. Dieckgraefe BK, Crimmins DL, Landt V, Houchen C, Anant S, Porche-Sorbet R, et al. Expression of the regenerating gene family in inflammatory bowel disease mucosa: Reg Iα upregulation, processing, and antiapoptotic activity. J Investig Med 2002; 50: 421-434
156. Porter EM, Bevins CL, Ghosh D, Ganz T. The multifaceted Paneth cell. Cell Mol Life Sci 2002; 59: 156-170
157. Putsep K, Axelsson LG, Boman A, Midtvedt T, Normark S, Boman HG, et al. Germ-free and colonized mice generate the same products from enteric prodefensins. J Biol Chem 2000; 275: 40478-40482
158. Mallow EB, Harris A, Salzman N, Russell JP, DeBerardinis RJ, Ruchelli E, et al. Human enteric defensins. Gene structure and developmental expression. J Biol Chem 1996; 271: 4038-4045
159. Hornef MW, Putsep K, Karlsson J, Refai E, Andersson M. Increased diversity of intestinal antimicrobial peptides by covalent dimer formation. Nat Immunol 2004; 5: 836-843
160. O'Neil DA, Porter EM, Elewaut D, Anderson GM, Eckmann L, Ganz T, et al. Expression and regulation of the human β-defensins hBD-1 and hBD-2 in intestinal epithelium. J Immunol 1999; 163: 6718-6724
161. Sherman H, Chapnik N, Froy O. Albumin and amino acids upregulate the expression of human β-defensin 1. Mol Immunol 2006; 43: 1617-1623
162. Zaalouk TK, Bajaj-Elliott M, George JT, McDonald V. Differential regulation of β-defensin gene expression during Cryptosporidium parvum infection. Infect Immun 2004; 72: 2772-2779
163. Dann SM, Eckmann L. Innate immune defenses in the intestinal tract. Curr Opin Gastroenterol 2007; 23: 115-120
164. Fahlgren A, Hammarstrom S, Danielsson A, Hammarstrom ML. β-Defensin-3 and -4 in intestinal epithelial cells display increased mRNA expression in ulcerative colitis. Clin Exp Immunol 2004; 137: 379-385
165. Walmsley RS, Gillen CD, Allan RN. Prognosis and management of Crohn's disease in the over-55 age group. Postgrad Med J 1997; 73: 225-229
166. Siddique ZL, Drozdov I, Floch J, Gustafsson BI, Stunes K, Pfragner R, et al. KRJ-I and BON cell lines: defining an appropriate enterochromaffin cell neuroendocrine tumor model. Neuroendocrinology 2009; 89: 458-470
167. Kuramoto H, Kadowaki M, Sakamoto H, Yuasa K, Todo A, Shirai R. Distinct morphology of serotonin-containing enterochromaffin (EC) cells in the rat distal colon. Arch Histol Cytol 2007; 70: 235-241
168. Hansen MB, Witte AB. The role of serotonin in intestinal luminal sensing and secretion. Acta Physiol (Oxford) 2008; 193: 311-323
169. Zanner R, Gratzl M, Prinz C. Expression of the endocytic proteins dynamin and amphiphysin in rat gastric enterochromaffin-like cells. J Cell Sci 2004; 117: 2369-2376
170. Heitz P, Polak JM, Timson DM, Pearse AG. Enterochromaffin cells as the endocrine source of gastrointestinal substance P. Histochemistry 1976; 49: 343-347
171. Cetin Y, Grube D. Immunoreactivities for chromogranin A and B, and secretogranin II in the guinea pig entero-endocrine system: cellular distributions and intercellular heterogeneities. Cell Tissue Res 1991; 264: 231-241
172. Raikhlin NT, Kvetnoy IM. Melatonin and enterochromaffine cells. Acta Histochem 1976; 55: 19-24.
173. Kim M, Cooke HJ, Javed NH, Carey HV, Christofi F, Raybould HE. D-glucose releases 5-hydroxytryptamine from human BON cells as a model of enterochromaffin cells. Gastroenterology 2001; 121: 1400-1406
174. Braun T, Voland P, Kunz L, Prinz C, Gratzl M. Enterochromaffin cells of the human gut: sensors for spices and odorants. Gastroenterology 2007; 132: 1890-1901
175. Modlin IM, Kidd M, Pfragner R, Eick GN, Champaneria MC. The functional characterization of normal and neoplastic human enterochromaffin cells. J Clin Endocrinol Metab 2006; 91: 2340-2348
176. Metz-Boutigue MH, Kieffer AE, Goumon Y, Aunis D. Innate immunity: involvement of new neuropeptides. Trends Microbiol 2003; 11: 585-592
177. Zhang D, Shooshtarizadeh P, Laventie BJ, Colin DA, Chich JF, Vidic J, et al. Two chromogranin A-derived peptides induce calcium entry in human neutrophils by calmodulin-regulated calcium independent phospholipase A2. PLoS One 2009; 4: e4501.
178. Ghia JE, Crenner F, Rohr S, Meyer C, Metz-Boutigue MH, Aunis D, et al. A role for chromogranin A (4-16), a vasostatin-derived peptide, on human colonic motility. An in vitro study. Regul Pept 2004; 121: 31-39
179. Ghia JE, Pradaud I, Crenner F, Metz-Boutigue MH, Aunis D, Angel F. Effect of acetic acid or trypsin application on rat colonic motility in vitro and modulation by two synthetic fragments of chromogranin A. Regul Pept 2005; 124: 27-35.
180. Yamamoto-Furusho JK, Korzenik JR. Crohn's disease: innate immunodeficiency? World J Gastroenterol 2006; 12: 6751-6755
181. Netea MG, Ferwerda G, de Jong DJ, Jansen T, Jacobs L, Kramer M, et al. Nucleotide-binding oligomerization domain-2 modulates specific TLR pathways for the induction of cytokine release. J Immunol 2005; 174: 6518-6523
182. Shi J. Defensins and Paneth cells in inflammatory bowel disease. Inflamm Bowel Dis 2007; 13: 1284-1292
183. Fellermann K, Wehkamp J, Herrlinger KR, Stange EF. Crohn's disease: a defensin deficiency syndrome? Eur J Gastroenterol Hepatol 2003; 15: 627-634
184. Wehkamp J, Harder J, Weichenthal M, Schwab M, Schaffeler E, Schlee M, et al. NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal α-defensin expression. Gut 2004; 53: 1658-1664
185. Lewin K. The Paneth cell in health and disease. Ann R Coll Surg Engl 1969; 44: 23-37.
186. Ahmad T, Armuzzi A, Bunce M, Mulcahy-Hawes K, Marshall SE, Orchard TR, et al. The molecular classification of the clinical manifestations of Crohn's disease. Gastroenterology 2002; 122: 854-866
187. Ogura Y, Lala S, Xin W, Smith E, Dowds TA, Chen FF, et al. Expression of NOD2 in Paneth cells: a possible link to Crohn's ileitis. Gut 2003; 52: 1591-1597
188. Hisamatsu T, Suzuki M, Reinecker HC, Nadeau WJ, McCormick BA, Podolsky DK. CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells. Gastroenterology 2003; 124: 993-1000.
189. Braat H, Peppelenbosch MP, Hommes DW. Immunology of Crohn's disease. Ann NY Acad Sci 2006; 1072: 135-154
190. Desreumaux P, Ernst O, Geboes K, Gambiez L, Berrebi D, Muller-Alouf H, et al. Inflammatory alterations in mesenteric adipose tissue in Crohn's disease. Gastroenterology 1999; 117: 73-81.
191. Cescutti P, Scussolin S, Herasimenka Y, Impallomeni G, Bicego M, Rizzo R. First report of a lyase for cepacian, the polysaccharide produced by Burkholderia cepacia complex bacteria. Biochem Biophys Res Commun 2006; 339: 821-826
192. Alberdi F, Jr, Alderton MR, Korolik V, Coloe PJ, Smith SC. Antibacterial proteins from porcine polymorphonuclear neutrophils. Immunol Cell Biol 1995; 73: 38-43.
193. Reddy ES, Bhargava PM. Seminalplasmin - an antimicrobial protein from bovine seminal plasma which acts in E. coli by specific inhibition of rRNA synthesis. Nature 1979; 279: 725-728
194. Agerberth B, Gunne H, Odeberg J, Kogner P, Boman HG, Gudmundsson GH. FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis. Proc Natl Acad Sci USA 1995; 92: 195-199
195. Skerlavaj B, Gennaro R, Bagella L, Merluzzi L, Risso A, Zanetti M. Biological characterization of two novel cathelicidin-derived peptides and identification of structural requirements for their antimicrobial and cell lytic activities. J Biol Chem 1996; 271: 28375-28381
196. Mahoney MM, Lee AY, Brezinski-Caliguri DJ, Huttner KM. Molecular analysis of the sheep cathelin family reveals a novel antimicrobial peptide. FEBS Lett 1995; 377: 519-522
197. Sawai MV, Waring AJ, Kearney WR, McCray PB, Jr, Forsyth WR, Lehrer RI, et al. Impact of single-residue mutations on the structure and function of ovispirin/novispirin antimicrobial peptides. Protein Eng 2002; 15: 225-232
198. Zanetti M, Storici P, Tossi A, Scocchi M, Gennaro R. Molecular cloning and chemical synthesis of a novel antibacterial peptide derived from pig myeloid cells. J Biol Chem 1994; 269: 7855-7858
199. Larrick JW, Hirata M, Shimomoura Y, Yoshida M, Zheng H, Zhong J, et al. Antimicrobial activity of rabbit CAP18-derived peptides. Antimicrob Agents Chemother 1993; 37: 2534-2539
200. Gennaro R, Skerlavaj B, Romeo D. Purification, composition, and activity of two bactenecins, antibacterial peptides of bovine neutrophils. Infect Immun 1989; 57: 3142-3146
201. Gudmundsson GH, Magnusson KP, Chowdhary BP, Johansson M, Andersson L, Boman HG. Structure of the gene for porcine peptide antibiotic PR-39, a cathelin gene family member: comparative mapping of the locus for the human peptide antibiotic FALL-39. Proc Natl Acad Sci USA 1995; 92: 7085-7089
202. Selsted ME, Harwig SS, Ganz T, Schilling JW, Lehrer RI. Primary structures of three human neutrophil defensins. J Clin Invest 1985; 76: 1436-1439
203. Oppenheim FG, Yang YC, Diamond RD, Hyslop D, Offner GD, Troxler RF. The primary structure and functional characterization of the neutral histidine-rich polypeptide from human parotid secretion. J Biol Chem 1986; 261: 1177-1182
204. Ouellette AJ, Pravtcheva D, Ruddle FH, James M. Localization of the cryptdin locus on mouse chromosome 8. Genomics 1989; 5: 233-239
205. Kohashi O, Ono T, Ohki K, Soejima T, Moriya T, Umeda A, et al. Bactericidal activities of rat defensins and synthetic rabbit defensins on Staphylococci, Klebsiella pneumoniae (Chedid, 277, and 8N3), Pseudomonas aeruginosa (mucoid and nonmucoid strains), Salmonella typhimurium (Ra, Rc, Rd, and Re of LPS mutants) and Escherichia coli. Microbiol Immunol 1992; 36: 369-380
206. Lin YQ, Li JY, Wang HY, Liu J, Zhang CL, Wang WT, et al. Cloning and identification of a novel sperm binding protein, HEL-75, with antibacterial activity and expressed in the human epididymis. Hum Reprod 2008; 23: 2086-2094
207. von Horsten HH, Schafer B, Kirchhoff C. SPAG11/isoform HE2C, an atypical anionic β-defensin-like peptide. Peptides 2004; 25: 1223-1233
208. Tran D, Tran P, Roberts K, Osapay G, Schaal J, Ouellette A, et al. Microbicidal properties and cytocidal selectivity of rhesus macaque theta defensins. Antimicrob Agents Chemother 2008; 52: 944-953
209. Storici P, Zanetti M. A novel cDNA sequence encoding a pig leukocyte antimicrobial peptide with a cathelin-like pro-sequence. Biochem Biophys Res Commun 1993; 196: 1363-1368
210. Raj PA, Karunakaran T, Sukumaran DK. Synthesis, microbicidal activity, and solution structure of the dodecapeptide from bovine neutrophils. Biopolymers 2000; 53: 281-292
211. Zucht HD, Raida M, Adermann K, Magert HJ, Forssmann WG. Casocidin-I: a casein-α s2 derived peptide exhibits antibacterial activity. FEBS Lett 1995; 372: 185-188
212. Pellegrini A, Thomas U, Bramaz N, Hunziker P, von Fellenberg R. Isolation and identification of three bactericidal domains in the bovine alpha-lactalbumin molecule. Biochim Biophys Acta 1999; 1426: 439-448
213. Fogaca AC, da Silva PI, Jr, Miranda MT, Bianchi AG, Miranda A, Ribolla PE, et al. Antimicrobial activity of a bovine hemoglobin fragment in the tick Boophilus microplus. J Biol Chem 1999; 274: 25330-25334
214. Kieffer AE, Goumon Y, Ruh O, Chasserot-Golaz S, Nullans G, Gasnier C, et al. The N- and C-terminal fragments of ubiquitin are important for the antimicrobial activities. FASEB J 2003; 17: 776-778
215. Berman H, Henrick K, Nakamura H, Markley JL. The worldwide Protein Data Bank (wwPDB): ensuring a single, uniform archive of PDB data. Nucleic Acids Res 2007; 35: D301-3.
216. Rozek A, Friedrich CL, Hancock RE. Structure of the bovine antimicrobial peptide indolicidin bound to dodecylphosphocholine and sodium dodecyl sulfate micelles. Biochemistry 2000; 39: 15765-15774
217. Wang G. Structures of human host defense cathelicidin LL-37 and its smallest antimicrobial peptide KR-12 in lipid micelles. J Biol Chem 2008; 283: 32637-32643
218. Bauer F, Schweimer K, Kluver E, Conejo-Garcia JR, Forssmann WG, Rosch P, et al. Structure determination of human and murine beta-defensins reveals structural conservation in the absence of significant sequence similarity. Protein Sci 2001; 10: 2470-2479
219. Hunter HN, Fulton DB, Ganz T, Vogel HJ. The solution structure of human hepcidin, a peptide hormone with antimicrobial activity that is involved in iron uptake and hereditary hemochromatosis. J Biol Chem 2002; 277: 37597-37603
220. Brodersen DE, Nyborg J, Kjeldgaard M. Zinc-binding site of an S100 protein revealed. Two crystal structures of Ca2+-bound human psoriasin (S100A7) in the Zn2+-loaded and Zn2+-free states. Biochemistry 1999; 38: 1695-1704
221. Hunter HN, Demcoe AR, Jenssen H, Gutteberg TJ, Vogel HJ. Human lactoferricin is partially folded in aqueous solution and is better stabilized in a membrane mimetic solvent. Antimicrob Agents Chemother 2005; 49: 3387-3395
222. Humphrey W, Dalke A, Schulten K. VMD: visual molecular dynamics. J Mol Graph 1996; 14: 27-8, 33-38
223. Adachi Y, Yoshio-Hoshino N, Nishimoto N. The blockade of IL-6 signaling in rational drug design. Curr Pharm Des 2008; 14(12): 1217-1224
224. Macfarlane GT, Blackett KL, Nakayama T, Steed H, Macfarlane S. The gut microbiota in inflammatory bowel disease. Curr Pharm Des 2009; 15(13): 1528-1536
225. Mitsuyama K, Yamasaki H, Kuwaki K, Takedatsu H, Sata M. Recent understanding of leukocytapheresis (LCAP) for the treatment of inflammatory bowel disease. Curr Pharm Des 2009; 15(18): 2110-2119